The agency said it was taking the action because studies found that the dye, also known as erythrosine, caused cancer in lab ...

A 5-year-old killed in a hyperbaric chamber fire last month in Michigan was receiving treatment for sleep apnea and ADHD, said an attorney for his family.

A federal appellate court has upheld the Drug Enforcement Administration’s denial of a Seattle doctor’s request to use ...

Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...

Alphamab Oncology has dosed the first subject in the randomised Phase III JSKN003-306 trial of its anti-human epidermal ...

A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...

The F.D.A. is making its biggest move yet to end smoking. It needs to be careful not to give rise to another public health ...

Netflix's new limited series retells the story of a wellness influencer who rejected traditional cancer treatments in favor ...

Most major sections of the new animal drug application for Laverdia-CA1 have been deemed complete by the FDA, bringing the ...

Aditya Bardia, MD, MPH, FASCO, medical oncologist, UCLA Health, discusses findings from the TROPION-Breast01 study on ...

An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...